Funder
U.S. Department of Health & Human Services | Centers for Disease Control and Prevention
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology
Reference33 articles.
1. WHO. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003–2018,
https://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/
(2018). Accessed Dec 2018.
2. Cox, N. J., Trock, S. C. & Burke, S. A. Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT). Curr. Top. Microbiol. Immunol. 385, 119–136 (2014).
3. Smith, G. J. & Donis, R. O. Nomenclature updates resulting from the evolution of avian influenza A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013–2014. Influenza Respir. Virus 9, 271–276 (2015).
4. Baz, M., Luke, C. J., Cheng, X., Jin, H. & Subbarao, K. H5N1 vaccines in humans. Virus Res. 178, 78–98 (2013).
5. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza, A. V. et al. Update on avian influenza A (H5N1) virus infection in humans. N. Engl. J. Med. 358, 261–273 (2008).
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献